Annals of internal medicine

• Latest
• Best
• Search…

• Ann. Intern. Med. · Oct 2023

  Comment Randomized Controlled Trial

  Cytisinicline increased smoking abstinence at 6 and 12 wk.

  Rigotti NA, Benowitz NL, Prochaska J, et al. Cytisinicline for smoking cessation: a randomized clinical trial. JAMA. 2023;330:152-160. 37432430.

  expand abstract… or not…

• Ann. Intern. Med. · Oct 2023

  Chronotype, Unhealthy Lifestyle, and Diabetes Risk in Middle-Aged U.S. Women : A Prospective Cohort Study.

  Evening chronotype may promote adherence to an unhealthy lifestyle and increase type 2 diabetes risk. ⋯ National Institutes of Health.

  read more… mark as read…

• Ann. Intern. Med. · Oct 2023

  Correction: Anticoagulant Therapy for Cancer-Associated Thrombosis.

  no abstract available

  keep going… or not…

• Ann. Intern. Med. · Oct 2023

  Review

  Outpatient Treatment of Confirmed COVID-19: A Living, Rapid Evidence Review for the American College of Physicians (Version 2).

  Clinicians and patients want to know the benefits and harms of outpatient treatment options for the Omicron variant of SARS-CoV-2. ⋯ American College of Physicians. (PROSPERO: CRD42023406456).

  read more… mark as read…

• Ann. Intern. Med. · Oct 2023

  Comment Randomized Controlled Trial

  In T2DM uncontrolled with noninsulin glucose-lowering agents, weekly icodec reduced HbA1c vs. daily degludec at 26 wk.

  Lingvay I, Asong M, Desouza C, et al. Once-weekly insulin icodec vs once-daily insulin degludec in adults with insulin-naive type 2 diabetes: the ONWARDS 3 randomized clinical trial. JAMA. 2023;330:228-237. 37354562.

  read more… or not…